- Home
- PROHBIG 100IU INJECTION 1ML
PROHBIG 100IU INJECTION 1ML Substitute
PROHBIG 100IU INJECTION 1ML Substitute
Verified Ingredients and Effects
Composition:
HEPATITIS B IMMUNOGLOBULIN-100I.U
Uses:
<p>PROHBIG 100IU INJECTION 1ML is used in the treatment of hepatitis B infection. The detailed uses of PROHBIG 100IU INJECTION 1ML are as follows:</p><ul><li><strong>Hepatitis B Treatment: </strong>PROHBIG 100IU INJECTION 1ML can be administered as part of a treatment plan for chronic Hepatitis B infection to help manage the virus and improve liver health.</li><li><strong>Post-Exposure Prophylaxis:</strong> PROHBIG 100IU INJECTION 1ML can be given after potential exposure to Hepatitis B, such as after a needlestick injury, to prevent the onset of the infection.</li><li><strong>Vaccination Boost: </strong>PROHBIG 100IU INJECTION 1ML may be utilised as a booster shot for individuals who have previously been vaccinated against Hepatitis B but require an additional dose to maintain immunity.</li></ul>
Medicinal Benefits:
PROHBIG 100IU INJECTION 1ML contains antibodies that act against the hepatitis B virus (HBV) made from the human plasma of the donor infected person. It contains proteins (immunoglobulin) that help neutralize the hepatitis B virus. It is given to prevent hepatitis B in people who are undergoing liver transplantation, in babies born to mothers with hepatitis B, in people who are exposed to infected blood products, in people who had sexual contact with an infected person, and in people who are living with an infected person. It provokes the immune system to produce antibodies against the hepatitis B virus, which damages the liver. PROHBIG 100IU INJECTION 1ML offers protection against the hepatitis B virus for 3-6 months.
FAQs
PROHBIG 100IU INJECTION 1ML is used to prevent hepatitis B virus post-exposure.
PROHBIG 100IU INJECTION 1ML contains 'hepatitis B immunoglobulin' used to prevent hepatitis B infection (affects the liver). It works by neutralizing the hepatitis B virus by provoking an individual's immune system through cell-mediated immunity.
Do not take live vaccines such as MMR (measles, mumps, and rubella), typhoid, yellow fever, varicella (chickenpox), and zoster (shingles) vaccine while taking PROHBIG 100IU INJECTION 1ML or for 3 months after taking PROHBIG 100IU INJECTION 1ML. This medicine may alter the action of these vaccines.
It is given to people undergoing liver transplantation, who are exposed to infected blood products, who had sexual contact with an infected person, who are living with an infected person, or who are caring for an infected person. It is also given in babies born to mothers with hepatitis B.
The hepatitis B vaccine stimulates the immune system to produce antibodies against the hepatitis B virus (HBV) and also it provides long-term protection against the virus. On the other hand, hepatitis B immunoglobulin contains antibodies that act against HBV and it is given when immediate protection against the virus is needed.
